Caitong International Asset Management Buys Eli Lilly Shares

Chinese asset management firm adds 1,951 shares of pharmaceutical giant to portfolio

Mar. 18, 2026 at 8:23am

Got story updates? Submit your updates here. ›

Caitong International Asset Management Co. Ltd., a Chinese asset management firm, bought a new position in shares of Eli Lilly and Company (NYSE:LLY) during the third quarter of 2025. The firm purchased 1,951 shares of the pharmaceutical company's stock, valued at approximately $1.49 million.

Why it matters

This investment by a major Chinese asset manager highlights the continued global interest in Eli Lilly, one of the world's leading pharmaceutical companies. Lilly's diverse portfolio of innovative medicines and therapies has made it an attractive long-term holding for institutional investors around the world.

The details

According to a recent 13F filing with the U.S. Securities and Exchange Commission, Caitong International Asset Management Co. Ltd. added the 1,951 Eli Lilly shares to its portfolio in the third quarter of 2025. The shares represented approximately 1% of Caitong's total assets under management at the time.

  • Caitong International Asset Management Co. Ltd. bought the Eli Lilly shares in the third quarter of 2025.

The players

Caitong International Asset Management Co. Ltd.

A Chinese asset management firm that invests in global equities and other financial instruments.

Eli Lilly and Company

A global pharmaceutical company headquartered in Indianapolis, Indiana that researches, develops, manufactures, and commercializes a broad range of medicines and therapies.

Got photos? Submit your photos here. ›

The takeaway

Caitong International's investment in Eli Lilly reflects the pharmaceutical company's continued appeal to global institutional investors seeking exposure to innovative, market-leading healthcare firms.